These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2026552)

  • 1. Helvecardins A and B, novel glycopeptide antibiotics. III. Biological properties.
    Takeuchi M; Katayama T; Inukai M
    J Antibiot (Tokyo); 1991 Mar; 44(3):278-81. PubMed ID: 2026552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRSA--the tip of the iceberg.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():3-10. PubMed ID: 16524422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
    Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
    J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
    Kanno H
    Nihon Rinsho; 1990 Oct; 48(10):2355-64. PubMed ID: 2177799
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of antimicrobial resistance].
    Hori S; Hiramatsu K
    Nihon Rinsho; 1994 Feb; 52(2):327-31. PubMed ID: 8126881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455.
    Yarlagadda V; Konai MM; Manjunath GB; Prakash RG; Mani B; Paramanandham K; Ranjan SB; Ravikumar R; Chakraborty SP; Roy S; Haldar J
    Int J Antimicrob Agents; 2015 Jun; 45(6):627-34. PubMed ID: 25900818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on the resistance of methicillin resistant Staphylococcus aureus to antimicrobial agents].
    Wang R; Nishioka K; Tanno Y
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):95-8. PubMed ID: 8070299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.
    Khare M; Keady D
    Expert Opin Pharmacother; 2003 Feb; 4(2):165-77. PubMed ID: 12562306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
    Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J
    Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus.
    Watanabe T; Ohashi K; Matsui K; Kubota T
    J Antimicrob Chemother; 1997 Apr; 39(4):471-6. PubMed ID: 9145819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent trend and development of novel antimicrobial agents for MRSA infections].
    Nishino T
    Nihon Rinsho; 1992 May; 50(5):1066-74. PubMed ID: 1324332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloropolysporins A, B and C, novel glycopeptide antibiotics from Faenia interjecta sp. nov. V. Comparative studies of the biological properties.
    Takatsu T; Katayama T; Nakajima M; Takahashi S; Haneishi T; Magaribuchi T; Tajima M
    J Antibiot (Tokyo); 1987 Jul; 40(7):946-52. PubMed ID: 3624073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redesign of glycopeptide antibiotics: back to the future.
    James RC; Pierce JG; Okano A; Xie J; Boger DL
    ACS Chem Biol; 2012 May; 7(5):797-804. PubMed ID: 22330049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of methicillin-resistant Staphylococcus aureus isolated from dogs in Korea.
    Pak SI; Han HR; Shimizu A
    J Vet Med Sci; 1999 Sep; 61(9):1013-8. PubMed ID: 10535519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D; Toshkova K; Gavrilova V
    Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galacardins A and B, new glycopeptide antibiotics.
    Takeuchi M; Takahashi S; Enokita R; Sakaida Y; Haruyama H; Nakamura T; Katayama T; Inukai M
    J Antibiot (Tokyo); 1992 Mar; 45(3):297-305. PubMed ID: 1577657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.
    Mallaval FO; Carricajo A; Delavenna F; Recule C; Fonsale N; Manquat G; Raffenot D; Rogeaux O; Aubert G; Tous J
    Clin Microbiol Infect; 2004 May; 10(5):459-61. PubMed ID: 15113326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.